Go back to News
NEWS
GA_P advises Qualitas Energy on the sale of 136MWp solar portfolio to Sonnedix
GA_P has advised Qualitas Energy on the sale of a 136MWp solar PV portfolio in Spain to Sonnedix.
This transaction is one of the most relevant that have been carried out in the energy sector in the last year. The portfolio comprises 169 solar PV plants located across the country. All the plants have been in operation since 2007-2014 and are, in their entirety, under the Spanish regulatory regime.
Advising on the transaction were: Pablo Fernández Cortijo, partner, Diego Martínez Colino, Claudia Barreiro, Fernando Aldavero, Corporate associates; Vanessa Armas, of counsel, Íñigo González de Echávarri, Banking and Finance associate and Juan Romero, Public and Regulatory of counsel.26
Read full article in El Economista.
Read full article in Expansión.
This transaction is one of the most relevant that have been carried out in the energy sector in the last year. The portfolio comprises 169 solar PV plants located across the country. All the plants have been in operation since 2007-2014 and are, in their entirety, under the Spanish regulatory regime.
Advising on the transaction were: Pablo Fernández Cortijo, partner, Diego Martínez Colino, Claudia Barreiro, Fernando Aldavero, Corporate associates; Vanessa Armas, of counsel, Íñigo González de Echávarri, Banking and Finance associate and Juan Romero, Public and Regulatory of counsel.26
Read full article in El Economista.
Read full article in Expansión.
Lawyer mentioned
Pablo Fernández Cortijo – Partner
Diego Martínez Colino – Partner
See all lawyers
See less lawyers
Category
Deal
Press contact
Sandra Cuesta
Director of Business Development, Marketing and Communications
Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
¡NEW!
Pharma & Healthcare No. 50
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
3 days ago
Resolved bank found liable as pledgee of third-party owned shares in the bank
The fiduciary nature of the managed investment relationship supports the view that the bank should be liable for the loss of the pledged item because there would not have been such loss had the client’s order been executed prior to the bank’s resolution — but not for the reason given in the judgment.
PUBLICATION
11 Sep, 2026
Public consultation now open on the Royal Decree regulating the requirements for energy sustainability, environmental sustainability, digital resilience and digital sovereignty applicable to data centres
PUBLICATION
31 Jul, 2026
Automotive and Sustainable Mobility No. 31
Summary of legislative and jurisprudential developments relating to the automotive sector.
PUBLICATION
08 Jul, 2026
Are company directors directly liable for torts attributable to the company?
Debt from liability in tort for third-party damage or loss arises directly against the directors, without prejudice to the fact that, pursuant to Article 38 CC, it also arises simultaneously against the company, to which the non-contractual acts or omissions of its directors are also attributed. This is so true that the liable company (in debt, for example, with the tax authorities as the person liable for the surcharge and the tax penalty owed) may bring an action for contribution against its directors after settling the debt.
PUBLICATION
23 Jun, 2026
Pharma & Healthcare No. 49
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
18 Jun, 2026
Royal Decree 415/2026: key aspects of the new health technology assessment system
Royal Decree 415/2026 establishes a unified framework for the assessment of health technologies in Spain, distinguishing between the technical assessment and the administrative decision regarding funding, pricing or inclusion in the service catalogue, and incorporating the requirements of Regulation (EU) 2021/2282. The aspect that raises the most legal questions in this new piece of legislation is the connection between the assessment regulated by the Royal Decree and the procedures for funding, pricing, and inclusion in the service catalogue.
PUBLICATION
09 Jun, 2026
The “serious risk” of financial assistance (Supreme Court (First Chamber) Judgment of 5 May 2026)
This paper critically analyses the Supreme Court ruling of 5May 2026, which applies the prohibition on financial assistance to a case involving the sale of treasury shares with deferred payment to the shareholders of the assisting company.
PUBLICATION
01 Jun, 2026
NGT plant patenting: betwixt and between regulatory continuity and expectations
The evolution of the concept of genetically modified organisms in the European Union in light of new genomic techniques (NGTs) is examined, along with the regulatory response that introduces a distinction between two categories of NGT plants, making the regime more flexible for those that can be considered equivalent to conventional plants. It also highlights that the institutional agreement reflected in the Council’s position represents a significant shift from the case law of the Court of Justice. Regarding patents, it highlights the absence of substantial changes, opting instead for a cautious approach based on transparency, monitoring, and possible future intervention.